Open AccessNovel Therapies to Inhibit Mucus Synthesis and Secretion in Airway Hypersecretory Diseases
Author(s) -
Emily V.S. Ha,
Duncan F. Rogers
Publication year - 2015
Publication title -
pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.51
H-Index - 59
eISSN - 1423-0313
pISSN - 0031-7012
DOI - 10.1159/000442794
Subject(s) - mucus , mucin , marcks , secretion , mucociliary clearance , medicine , epidermal growth factor receptor , copd , submucosal glands , roflumilast , asthma , immunology , pharmacology , kinase , biology , receptor , protein kinase c , lung , microbiology and biotechnology , pathology , ecology
In asthma and chronic obstructive pulmonary disease (COPD), airway mucus hypersecretion contributes to impaired mucociliary clearance, mucostasis and, potentially, the development of mucus plugging of the airways.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom